APA (7th ed.) Citation

A, Y., MJ, N., H, M., K, N., & M, S. (2021). MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3. Frontiers in pharmacology, 12, 667474. https://doi.org/10.3389/fphar.2021.667474

Chicago Style (17th ed.) Citation

A, Yamamura, Nayeem MJ, Muramatsu H, Nakamura K, and Sato M. "MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3." Frontiers in Pharmacology 12 (2021): 667474. https://doi.org/10.3389/fphar.2021.667474.

MLA (9th ed.) Citation

A, Yamamura, et al. "MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3." Frontiers in Pharmacology, vol. 12, 2021, p. 667474, https://doi.org/10.3389/fphar.2021.667474.